KLRD1 and cancer: Since NK-92 cells display an activated NK-cell phenotype while expressing only few of the inhibitory NK-cell receptors such as KIRs and NKG2A,16,23 their ability to differentiate between cancer and normal cells carrying the CAR target antigen may be impaired to some extent.